FUMAGALLI, CATERINA
FUMAGALLI, CATERINA
Universita' degli Studi di MILANO
Activity of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring rare epidermal growth factor receptor mutations
2011 T. De Pas, F. Toffalorio, M. Manzotti, C. Fumagalli, G. Spitaleri, C. Catania, A. Delmonte, M. Giovannini, L. Spaggiari, F. de Braud, M. Barberis
CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer
2016 S. Rizzo, F. Petrella, V. Buscarino, F. de Maria, S. Raimondi, M. Barberis, C. Fumagalli, G. Spitaleri, C. Rampinelli, F. de Marinis, L. Spaggiari, M. Bellomi
Gene expression profiling reveals GC and CEACAM1 as new tools in the diagnosis of lung carcinoids
2014 F. Toffalorio, E. Belloni, M. Barberis, G. Bucci, L. Tizzoni, G. Pruneri, C. Fumagalli, G. Spitaleri, C. Catania, F. Melotti, P.G. Pelicci, L. Spaggiari, T. De Pas
Phase Ib of sorafenib in combination with everolimus in patients with advanced solid tumors, selected on the basis of molecular targets
2014 F. Toffalorio, G. Spitaleri, C. Catania, L. Dal Zotto, C. Noberasco, A. Delmonte, M. Santarpia, F. Vecchio, V. Brunelli, C. Rampinelli, M. Barberis, C. Fumagalli, M. Zucchetti, M. Zangarini, T. Diena, R. Danesi, F. De Braud, T. De Pas
| Titolo | Data di pubblicazione | Autori | Tipo | File | Abstract |
|---|---|---|---|---|---|
| Activity of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring rare epidermal growth factor receptor mutations | 1-nov-2011 | C. FumagalliL. SpaggiariF. de Braud + | Article (author) | - | |
| CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer | 1-gen-2016 | S. RizzoF. PetrellaV. BuscarinoF. de MariaS. RaimondiC. FumagalliC. RampinelliL. SpaggiariM. Bellomi + | Article (author) | - | |
| Gene expression profiling reveals GC and CEACAM1 as new tools in the diagnosis of lung carcinoids | 4-mar-2014 | G. BucciG. PruneriC. FumagalliC. CataniaP.G. PelicciL. Spaggiari + | Article (author) | - | |
| Phase Ib of sorafenib in combination with everolimus in patients with advanced solid tumors, selected on the basis of molecular targets | 1-apr-2014 | C. RampinelliC. FumagalliF. De Braud + | Article (author) | - |